RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $168,468,000 | -43.1% | 30,575 | 0.0% | 0.00% | – |
| Q4 2021 | $295,966,000 | -48.7% | 30,575 | -5.3% | 0.00% | – |
| Q3 2021 | $577,488,000 | -41.7% | 32,298 | -20.4% | 0.00% | – |
| Q2 2021 | $990,533,000 | +50.1% | 40,579 | +63.0% | 0.00% | – |
| Q1 2021 | $659,850,000 | +624.5% | 24,900 | +107.5% | 0.00% | – |
| Q4 2020 | $91,080,000 | +51.5% | 12,000 | 0.0% | 0.00% | – |
| Q3 2020 | $60,120,000 | -52.8% | 12,000 | -43.7% | 0.00% | – |
| Q2 2020 | $127,362,000 | +177.9% | 21,298 | +106.8% | 0.00% | – |
| Q1 2020 | $45,835,000 | -53.2% | 10,300 | 0.0% | 0.00% | – |
| Q4 2019 | $97,850,000 | +21.0% | 10,300 | 0.0% | 0.00% | – |
| Q3 2019 | $80,855,000 | -50.1% | 10,300 | 0.0% | 0.00% | – |
| Q2 2019 | $162,019,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abbot Financial Management, Inc. | 1,411,775 | $25,243,000 | 11.48% |
| Flagship Pioneering Inc. | 38,506,526 | $688,497,000 | 7.21% |
| Artal Group S.A. | 4,155,625 | $74,303,000 | 1.66% |
| HARBOURVEST PARTNERS LLC | 986,878 | $17,645,000 | 1.66% |
| Nan Fung Group Holdings Ltd | 56,768 | $1,015,000 | 0.32% |
| Lombard Odier Asset Management (Switzerland) SA | 245,013 | $4,381,000 | 0.27% |
| Bellwether Advisors, LLC | 29,383 | $525,000 | 0.18% |
| PDT Partners, LLC | 65,991 | $1,180,000 | 0.08% |
| Virtus ETF Advisers LLC | 7,478 | $134,000 | 0.06% |
| HITE Hedge Asset Management LLC | 24,911 | $445,000 | 0.06% |